Home » Newsletters » BioWorld

BioWorld

Dec. 20, 1993

View Archived Issues

CALGENE RAISES $9.2M IN SHELF OFFERING

DNAP FILES FOR STOCK OFFERING

You Can't Always Believe In What You Read

TAXOL APPROVED IN CANADA FOR BREAST CANCER

APPOINTMENTS AND ADVANCEMENTS

T CELL SCIENCE, AB ASTRA REVISE AGREEMENT

CYPROS AMENDS OFFERING

BIOSTAR RAISES $8.2M IN FIRST PRIVATE PLACEMENT

XOMA, M.D. ANDERSON CROSS-LICENSE TIF TECHNOLOGY

PULMOZYME RECOMMENDED FOR APPROVAL IN EUROPE

VERTEX FOLLOWS R&D DEAL WITH OFFERING

ATS OFFERS 2.5 MILLION SHARES

DEAL WITH MERCK WORTH UP TO $20M TO SYNAPTIC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...